Literature DB >> 2261447

Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.

M Rafalski1, J D Lear, W F DeGrado.   

Abstract

Peptides representing the N-terminal 23 residues of the surface protein gp41 of LAV1a and LAVmal strains of the human immunodeficiency virus were synthesized and their interactions with phospholipid vesicles studied. The peptides are surface-active and penetrate lipid monolayers composed of negatively charged but not neutral lipids. Similarly, the peptides induce lipid mixing and solute (6-carboxyfluorescein) leakage of negatively charged, but not neutral, vesicles. Circular dichroism and infrared spectroscopy show that at low peptide:lipid ratios (approximately 1:200), the peptides bind to negatively charged vesicles as alpha-helices. At higher peptide:lipid ratios (1:30), a beta conformation is observed for the LAV1a peptide, accompanied by a large increase in light scattering. The LAVmal peptide showed less beta-structure and induced less light scattering. With neutral vesicles, only the beta conformation and a peptide:lipid ratio-dependent increase in vesicle suspension light scattering were observed for both peptides. We hypothesize that the inserted alpha-helical form causes vesicle membrane disruption whereas the surface-bound beta form induces aggregation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2261447     DOI: 10.1021/bi00486a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  53 in total

1.  Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer.

Authors:  A S Ulrich; W Tichelaar; G Förster; O Zschörnig; S Weinkauf; H W Meyer
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

2.  Macromolecular uptake is a spontaneous event during mitosis in cultured fibroblasts: implications for vector-dependent plasmid transfection.

Authors:  Pierre Pellegrin; Anne Fernandez; Ned J C Lamb; René Bennes
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

3.  Polymorphism and interactions of a viral fusion peptide in a compressed lipid monolayer.

Authors:  G Schwarz; S E Taylor
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

4.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Irregular structure of the HIV fusion peptide in membranes demonstrated by solid-state NMR and MD simulations.

Authors:  Dorit Grasnick; Ulrich Sternberg; Erik Strandberg; Parvesh Wadhwani; Anne S Ulrich
Journal:  Eur Biophys J       Date:  2011-01-28       Impact factor: 1.733

6.  Analysis of local conformation of membrane-bound and polycrystalline peptides by two-dimensional slow-spinning rotor-synchronized MAS exchange spectroscopy.

Authors:  Charles M Gabrys; Jun Yang; David P Weliky
Journal:  J Biomol NMR       Date:  2003-05       Impact factor: 2.835

Review 7.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

8.  Enhancement of enveloped virus entry by phosphatidylserine.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers.

Authors:  Yinling Li; Lukas K Tamm
Journal:  Biophys J       Date:  2007-05-18       Impact factor: 4.033

Review 10.  Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

Authors:  Judith M White; Sue E Delos; Matthew Brecher; Kathryn Schornberg
Journal:  Crit Rev Biochem Mol Biol       Date:  2008 May-Jun       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.